Rasagilin Sandoz 1 mg - Tabletten

Recall | Medicines | 13/06/2022

The marketing authorisation holder informed its customers on June 13, 2022 that the nitrosamine levels of the listed batch is above the permitted acceptable daily dose.

As a precautionary measure, the affected batch is recalled.

Name of the medicinal product Rasagilin Sandoz 1 mg - Tabletten
Marketing authorisation number(s) 136653
CIP code 4229596
Marketing authorisation holder Sandoz GmbH
Batch number(s) JZ6984
Expiry date 02/28/2023
Classification of the recall 2
Depth of recall Pharmacies
BASG reference number INS-640.001-3905

Further inquiry note